Literature DB >> 23746074

Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection.

Haiying Li1, Jacqueline Gillis, R Paul Johnson, R Keith Reeves.   

Abstract

The objective of this study was to determine the systemic effects of chronic simian immunodeficiency virus (SIV) infection on plasmacytoid dendritic cells (pDCs). pDCs play a critical role in antiviral immunity, but current data are conflicting on whether pDCs inhibit HIV/SIV replication, or, alternatively, contribute to chronic immune activation and disease. Furthermore, previous pDC studies have been complicated by incomplete descriptions of generalized depletion during HIV/SIV infection, and the effects of infection on pDCs outside peripheral blood remain unclear. In scheduled-sacrifice studies of naive and chronically SIV-infected rhesus macaques we evaluated the distribution and functionality of pDCs in multiple tissues using surface and intracellular polychromatic flow cytometry. As previously observed, pDCs were reduced in peripheral blood and spleens, but were also depleted in non-lymphoid organs such as the liver. Interestingly, pDCs accumulated up to fourfold in jejunum, colon and gut-draining lymph nodes, but not in peripheral lymph nodes. Most unexpectedly, SIV infection induced a multi-functional interferon-α, tumour necrosis factor-α, and macrophage inflammatory protein-1β cytokine secretion phenotype, whereas in normal animals these were generally distinct and separate functions. Herein we show a systemic redistribution of pDCs to gut tissues and gut-draining lymph nodes during chronic SIV infection, coupled to a novel multi-functional cytokine-producing phenotype. While pDC accumulation in the mucosa could aid in virus control, over-production of cytokines from these cells could also contribute to the increased immune activation in the gut mucosa commonly associated with progressive lentivirus infections.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  interferon-α; plasmacytoid dendritic cells; simian immunodeficiency virus

Mesh:

Year:  2013        PMID: 23746074      PMCID: PMC3784170          DOI: 10.1111/imm.12132

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus.

Authors:  S Patterson; A Rae; N Hockey; J Gilmour; F Gotch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Authors:  Jihed Chehimi; Donald E Campbell; Livio Azzoni; Darlene Bacheller; Emmanouil Papasavvas; Ghassen Jerandi; Karam Mounzer; Jay Kostman; Giorgio Trinchieri; Luis J Montaner
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

3.  SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa.

Authors:  R Keith Reeves; Tristan I Evans; Jacqueline Gillis; Fay E Wong; Guobin Kang; Qingsheng Li; R Paul Johnson
Journal:  J Infect Dis       Date:  2012-06-18       Impact factor: 5.226

4.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

Authors:  A Nichole Cline; Julian W Bess; Michael Piatak; Jeffrey D Lifson
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

5.  Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.

Authors:  Anna Smed-Sörensen; Karin Loré; Jayanand Vasudevan; Mark K Louder; Jan Andersson; John R Mascola; Anna-Lena Spetz; Richard A Koup
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.

Authors:  R Keith Reeves; Premeela A Rajakumar; Tristan I Evans; Michelle Connole; Jacqueline Gillis; Fay E Wong; Yury V Kuzmichev; Angela Carville; R Paul Johnson
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

7.  Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques.

Authors:  Suefen Kwa; Sunil Kannanganat; Pragati Nigam; Mariam Siddiqui; Ravi Dyavar Shetty; Wendy Armstrong; Aftab Ansari; Steven E Bosinger; Guido Silvestri; Rama Rao Amara
Journal:  Blood       Date:  2011-06-21       Impact factor: 22.113

8.  Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.

Authors:  Barbara Schmidt; Iain Scott; Robert G Whitmore; Hillary Foster; Sue Fujimura; Juergen Schmitz; Jay A Levy
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

9.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.

Authors:  Heather Donaghy; Brian Gazzard; Frances Gotch; Steven Patterson
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 10.  Microbial translocation, immune activation, and HIV disease.

Authors:  Nichole R Klatt; Nicholas T Funderburg; Jason M Brenchley
Journal:  Trends Microbiol       Date:  2012-10-11       Impact factor: 17.079

View more
  9 in total

Review 1.  Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.

Authors:  Vincent C Lombardi; Svetlana F Khaiboullina
Journal:  Clin Immunol       Date:  2014-04-24       Impact factor: 3.969

Review 2.  Type I interferon: understanding its role in HIV pathogenesis and therapy.

Authors:  Steven E Bosinger; Netanya S Utay
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

3.  Antigen-presenting cell candidates for HIV-1 transmission in human distal colonic mucosa defined by CD207 dendritic cells and CD209 macrophages.

Authors:  Gloria C Preza; Karen Tanner; Julie Elliott; Otto O Yang; Peter A Anton; Maria-Teresa Ochoa
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-10       Impact factor: 2.205

4.  Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection.

Authors:  S M Dillon; E J Lee; C V Kotter; G L Austin; S Gianella; B Siewe; D M Smith; A L Landay; M C McManus; C E Robertson; D N Frank; M D McCarter; C C Wilson
Journal:  Mucosal Immunol       Date:  2015-04-29       Impact factor: 7.313

Review 5.  Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity.

Authors:  Rebecca N Metzger; Anne B Krug; Katharina Eisenächer
Journal:  Viruses       Date:  2018-03-23       Impact factor: 5.048

6.  Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection.

Authors:  Erin Heather Doyle; Adeeb Rahman; Costica Aloman; Arielle L Klepper; Ahmed El-Shamy; Francis Eng; Chiara Rocha; Sang Kim; Brandy Haydel; Sander S Florman; M Isabel Fiel; Thomas Schiano; Andrea D Branch
Journal:  PLoS Pathog       Date:  2019-07-29       Impact factor: 6.823

7.  Gut-Associated Plasmacytoid Dendritic Cells Display an Immature Phenotype and Upregulated Granzyme B in Subjects with HIV/AIDS.

Authors:  Sergei V Boichuk; Svetlana F Khaiboullina; Bulat R Ramazanov; Gulshat R Khasanova; Karina A Ivanovskaya; Evgeny Z Nizamutdinov; Marat R Sharafutdinov; Ekaterina V Martynova; Kenny L DeMeirleir; Jan Hulstaert; Vladimir A Anokhin; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Immunol       Date:  2015-09-24       Impact factor: 7.561

8.  E2-2, a novel immunohistochemical marker for both human and monkey plasmacytoid dendritic cells.

Authors:  Jianping Ma; Haisheng Yu; Xiangyun Yin; Menglan Cheng; Quanxing Shi; Zhao Yin; Xiaohua Nie; Wang Shouli; Liguo Zhang
Journal:  Biophys Rep       Date:  2016-04-11

Review 9.  Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.

Authors:  Andrew Soper; Izumi Kimura; Shumpei Nagaoka; Yoriyuki Konno; Keisuke Yamamoto; Yoshio Koyanagi; Kei Sato
Journal:  Front Immunol       Date:  2018-01-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.